NEW YORK, Jan. 11, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
IntroductionThis analysis examines the historical and forecast performance for Johnson & Johnson in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits
* Gain insight into Johnson & Johnson's strategic outlook across the next 6 years* Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source
HighlightsStrategic insight into the prospects for Johnson & Johnson over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.
Your key questions answered* Benchmark Johnson & Johnson's performance against key rivals in the prescription pharmaceutical sector* Analyze how J&J will implement lifecycle management strategies across its portfolio as a means to combat patent expiries and generic competition* Assess J&J's diverse healthcare offering and how this will act to maintain operating profit growth despite a forecast decline in Rx drug revenue
To order this report:: Johnson & Johnson: PharmaVitae Profile
Copyright©2010 PR Newswire.
All rights reserved